Medical Program: Innovative Molecules in Immuno-oncology: Revolutionizing Cancer Treatment

Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Innovative Molecules in Immuno-Oncology: Revolutionizing Cancer Treatment

Innovative Molecules in Immuno-Oncology: Revolutionizing Cancer Treatment
    Join us as we explore the rationale for using bispecific, bifunctional fusion protein molecules as treatment for a variety of cancers.
    • In Partnership with

    • Overview

      Get a closer look at the newest development in cancer immunotherapy: the bifunctional fusion protein.

      Could this small but mighty protein designed to block two signaling pathways used by tumor cells to escape immune system control be the key to managing both tumor growth and metastasis?

      For more episodes in this series, visit

    • Commercial Support

      This activity is supported by an independent medical education grant provided by Merck KGaA, Darmstadt, Germany.

    Facebook Comments

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio



    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.